Analysts' Actions: AMD AMZN FOXA PNRA VMW


Albermarle ( ALB) was downgraded at Sterne Agee to neutral from buy. Estimates were also cut, given a slower growth outlook, Sterne Agee said.

Align Technology ( ALGN) was upgraded at Cantor Fitzgerald to buy from hold. $60 price target. Volume and pricing trends are improving, Cantor said.

Advanced Micro ( AMD) was downgraded at Bank of America/Merrill Lynch to neutral from buy. Company remains leveraged to slower PC growth, BofA/Merrill said. $4.50 price target. ( AMZN) was upgraded at UBS to buy from neutral. Bullish secular backdrop for multichannel commerce accelerates revenue growth, UBS said. $385 price target.

Alpha Natural ( ANR) was downgraded at BMO Capital to underperform from market perform. $4 price target. Expect to see more production cuts at the company, BMO Capital said.

AthenaHealth ( ATHN) was upgraded at Sterne Agee to buy. $132 price target. Estimates also upped, as core sales growth should accelerate in the coming quarters, Sterne Agee said.

Aspen Technology ( AZPN) was downgraded at J.P. Morgan to neutral from overweight. $38 price target. Valuation call, J.P. Morgan said.

Baxter ( BAX) was downgraded at Morgan Stanley to equal-weight from overweight. Estimates were also cut, given lower expected Advate growth, Morgan Stanley said.

Peabody Energy ( BTU) was upgraded at BMO Capital to outperform from market perform. $23 price target. Costs are coming down in Australia and the stock is attractively valued, BMO Capital said.

CBOE Holdings ( CBOE) was upgraded at UBS to buy from neutral. Strong secular growth and valuation call, UBS said. $56 price target.

Cypress Semiconductor ( CY) was upgraded at Pacific Crest to sector perform from outperform. Valuation call, based on an $11 price target.

Essex Property Trust ( ESS) was upgraded at UBS to buy from neutral. High exposure to strong rental growth in West Coast and promising development pipeline in CA, UBS said. Valuation call, $180 price target.

Fairchild Semiconductor ( FCS) was downgraded at Canaccord Genuity to hold. Company offered a soft outlook for the fourth quarter and lacks near-term catalysts, Canaccord said. $12 price target.

Finish Line ( FINL) was initiated with a neutral rating and $25 price target at UBS.

If you liked this article you might like

7 Essential Rules for Investing in Tech Stocks

Wall Street Deflates in Pullback After Fed Excitement, No Records for Dow

Your Guide to Making a Lot of Money on the Driverless Car Boom